DS
AGN

DRW Securities’s Allergan plc AGN Stock Holding History

DRW Securities’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-14,568
Closed -$2.58M – 364
2020
Q1 		$2.58M Buy
14,568
+12,018
+471% +$2.26M 0.1% 56
2019
Q4 		$487K Buy
+2,550
New +$460K 0.02% 127
2018
Q1 		– Sell
-4,656
Closed -$762K – 513
2017
Q4 		$762K Buy
+4,656
New +$836K 0.08% 151
2016
Q2 		– Sell
-10,000
Closed -$2.31M – 100
2016
Q1 		$2.68M Sell
10,000
-27,500
-73% -$7.87M 0.16% 26
2015
Q4 		$11.7M Buy
+37,500
New +$11.2M 1.16% 7
2014
Q4 		– Sell
-2,000
Closed -$483K – 147
2014
Q3 		$483K Buy
+2,000
New +$448K 0.04% 47

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

DRW Securities's AGN Position: Q2 2020 in Review

DRW Securities sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 14,568 shares — an estimated $2.58M sold.

DRW Securities first reported a position in AGN in Q3 2014 and held it in 6 quarters. The position peaked at $11.7M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • DRW Securities reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • DRW Securities sold 14,568 Allergan plc shares in Q2 2020, an estimated $2.58M.
  • DRW Securities first reported a position in Allergan plc in Q3 2014 and held it in 6 quarters.
  • DRW Securities's Allergan plc position peaked at $11.7M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on DRW Securities's 13F filing for Q2 2020, filed 14 Aug 2020.